Apoptosis and cancer chemotherapy

G Makin1, C Dive

  • 1CRC Molecular and Cellular Pharmacology Group, School of Biological Sciences, G38 Stopford Building, Oxford Road, Manchester, UK M13 9PT. guy.makin@man.ac.uk

Trends in Cell Biology
|October 31, 2001
PubMed

Insights

Understanding drug-induced apoptosis is key to overcoming cancer drug resistance. A new framework highlights how balancing survival and death signals, particularly involving Bcl-2 family proteins, offers therapeutic targets for cancer treatment.

Area of Science:

  • Cancer Biology
  • Molecular Oncology
  • Cell Death Mechanisms

Background:

  • Growing interest in apoptosis (programmed cell death) among cancer biologists.
  • Hope that understanding cell death mechanisms will elucidate tumor drug resistance.
  • Need for a framework to understand drug-induced apoptosis in cancer.

Purpose of the Study:

  • To describe a framework for drug-induced apoptosis in cancer.
  • To identify how intrinsic and extrinsic survival signals interact with drug-induced death signals.
  • To explore therapeutic intervention points for overcoming drug resistance.

Main Methods:

  • Analysis of the balance between pro- and anti-apoptotic signals.
  • Investigation of the role of Bcl-2 family proteins in controlling cellular fate.
  • Framework development based on mechanistic understanding of apoptosis.

Main Results:

  • A framework for drug-induced apoptosis has been described.
  • Pro- and anti-apoptotic signals converge on Bcl-2 family proteins.
  • This balance dictates the ultimate cellular fate.

Conclusions:

  • The described framework identifies multiple points for therapeutic intervention against drug resistance.
  • Novel molecular targets for inducing apoptosis in cancer cells have been generated.
  • Mechanistic insights into apoptosis can inform cancer drug resistance strategies.

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...